Recent data on the efficacy of tirzepatide demonstrate that incretin dual agonists have the potential to more effectively reduce HbA 1c and bodyweight than GLP-1R agonists alone [5]
JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function
Zafardoust S, Kazemnejad S, Darzi M, Fathi-Kazerooni M, Rastegari H, Mohammadzadeh A
It is not for human consumption, medical, diagnostic, or veterinary use
By: Sam Brusco Associate Editor Dexcom has announced Dexcom Flex, a new continuous glucose monitoring (CGM) system designed for adults with type 2 diabetes who arent using intensive insulin therapy
Unlike single-mechanism approaches, this combination leverages the distinct but overlapping appetite regulatory pathways of both incretin and amylin systems, creating a more comprehensive intervention for obesity and type 2 diabetes